<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01385943</url>
  </required_header>
  <id_info>
    <org_study_id>2009/4714</org_study_id>
    <nct_id>NCT01385943</nct_id>
  </id_info>
  <brief_title>VivaNet Study. A Multicenter Study of Confocal Reflectance Microscopy in Telemedicine</brief_title>
  <acronym>EUNET</acronym>
  <official_title>VivaNet Study. A Multicenter Study of Confocal Reflectance Microscopy in Telemedicine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lucid, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Clinic of Barcelona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario Ramon y Cajal</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital del Mar</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Modena and Reggio Emilia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Arcispedale Santa Maria Nuova-IRCCS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Lucid, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to test a protocol that uses clinical pictures, confocal
      reflectance microscopy images and dermoscopic information in a telemedicine platform. This
      protocol will test the technologies and diagnostic performance of dermoscopy and confocal
      reflectance microscopy in a randomized prospective multicenter study in five different
      centers in Europe.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In vivo confocal reflectance microscopy (CRM) is a non-invasive method for the in vivo
      (without cutting into the skik) examination of skin tumors. CRM produces cellular images with
      resolution comparable to histopathology. The procedure is painless, takes about ten minutes
      and has no documented side effects. Studies performed in the past decade have correlated CRM
      features in benign (non-cancerous) and malignant (cancerous) skin lesions such as moles and
      melanomas, as well as features of inflammatory lesions (such as allergic skin reactions) to
      histopathology.

      Dermoscopy is a complementary technique that has been proven to be superior to the naked eye
      for the diagnosis of melanoma as well as some non-melanocytic skin tumors. Recently,
      correlation of dermoscopic and CRM structures has focused interest in the research in
      different groups that show that both are complementary and render in combination a better
      understanding of skin disease.

      In this study, patients from several research centers in Europe, with lesions suspicious for
      malignancy and scheduled for biopsy will be asked if they would like to participate in the
      study. If they consent to the study, first, a clinical photograph will be taken of the
      lesion. Second, a dermoscopic image will be taken of the lesion, and third, CRM images will
      be taken of the lesion. Finally, the biopsy will be performed as per the standard of care.
      The images will be sent over a secure, private internet connection to physicians specially
      trained in the interpretation of dermoscopic and CRM images. An electronic report will be
      completed and returned to the Study Coordinator, who will correlate the results with the
      histopathologic diagnosis.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2011</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic accuracy, in terms of sensitivity, specificity, positive and negative predictive values with respect to histopathologic diagnosis.</measure>
    <time_frame>Study participation will be no longer than three months for patients requiring follow up, and no longer than one office visit (approximately one hour) for patients being biopsied the same day they are imaged.</time_frame>
    <description>Clinical pictures, dermoscopic pictures, confocal images and tissue biopsy will be obtained in a single study visit unless the physician determines that short-term (3 months) follow up is more appropriate, then the patient will be asked to return in three months for additional examination.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Differences between dermoscopy/confocal microscopy, and dermoscopy plus confocal microscopy</measure>
    <time_frame>Study participation will be no longer than three months for patients requiring follow up, and no longer than one office visit (approximately one hour) for patients being biopsied the same day they are imaged.</time_frame>
    <description>Clinical pictures, dermoscopic pictures, confocal images and tissue biopsy will be obtained in a single study visit as described under Primary Outcomes, unless the physician determines that short-term (3 months) follow up is more appropriate, then the patient will be asked to return in three months for additional examination.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Skin Cancer</condition>
  <condition>Skin Lesions</condition>
  <arm_group>
    <arm_group_label>Skin Cancer</arm_group_label>
    <description>Patients from dermatology practices throughout Europe that have a skin lesion or tumor requiring a biopsy for diagnosis.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Cutaneous tissue specimens in the form of histopathology slides and tissue blocks, clinical
      pictures, dermoscopic pictures and confocal microscopy images
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients from private dermatology clinics and university dermatology practices throughout
        Europe that have a skin lesion suspicious for malignancy under clinical non-aided
        examination.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any skin tumor considered suspicious for malignancy under clinical non-aided
             examination

          -  Histopathologic study of the tumor or short term follow up (3 months) to confirm
             benignity

          -  Clinical information and images available

          -  Adequate imaging by dermoscopy and CRM according to the protocol of the study

          -  Consent form signed by the patient

        Exclusion Criteria:

          -  Lesions with ulcerations obscuring more than 75% of the confocal mosaic field of view.

          -  Lesions with clinically appreciable scar.

          -  Lesions in locations not amenable to imaging with the confocal microscope.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Josep Malvehy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Clinic of Barcelona, Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Giovanni Pellacani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Policlinico Hospitale in Modena, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Modena and Reggio Emilia</name>
      <address>
        <city>Modena</city>
        <zip>42100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arcispedale Santa Maria Nuova</name>
      <address>
        <city>Reggio Emilia</city>
        <zip>42100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Dermatology, Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diagnosis Dermatologica</name>
      <address>
        <city>Barcelona</city>
        <zip>08015</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic of Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Ram√≥n y Cajal</name>
      <address>
        <city>Madrid</city>
        <zip>28049</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2011</study_first_submitted>
  <study_first_submitted_qc>June 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2011</study_first_posted>
  <last_update_submitted>September 27, 2013</last_update_submitted>
  <last_update_submitted_qc>September 27, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 30, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Reflectance Confocal Microscopy</keyword>
  <keyword>Dermoscopy</keyword>
  <keyword>Clinical Photos</keyword>
  <keyword>Telemedicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

